Right now, the biotech sector and Nasdaq are moving in lockstep.
Thus far in 2019, the iShares Nasdaq Biotechnology ETF (IBB) has gained 18.76%. By comparison, the technology-heavy Nasdaq index is up just over 19% this year.
Back in 1998, the same pattern was forming before biotech stocks truly broke out.